1. Hematological indices of erythropoietin administration in athletes
- Author
-
Giovanni Grazzi, Fabio Manfredini, C. Guglielmini, E. De Paoli Vitali, M. Masotti, Gianni Mazzoni, S. Bartalotta, Giorgio Ricci, I. Casoni, C. Borsetto, G. P. Franzè, F. Conconi, F. Rigolin, M. Patracchini, and E. Ballarin
- Subjects
Adult ,Erythrocyte Indices ,Male ,medicine.medical_specialty ,Erythrocytes ,Reticulocytes ,Doping ,Erythropoietin ,Injections, Subcutaneous ,Iron ,Population ,Physiology ,Physical Therapy, Sports Therapy and Rehabilitation ,Hematocrit ,Hemoglobins ,hemic and lymphatic diseases ,Internal medicine ,Fetal hemoglobin ,medicine ,Humans ,Orthopedics and Sports Medicine ,education ,Mean corpuscular volume ,Fetal Hemoglobin ,Erythrocyte Volume ,education.field_of_study ,Hematology ,medicine.diagnostic_test ,business.industry ,Transferrin ,Oxygen transport ,Creatine ,Ferritins ,Immunology ,Erythrocyte Count ,gamma-Globulins ,Hemoglobin ,business ,Sports ,medicine.drug - Abstract
Recombinant human erythropoietin (EPO), commercially available since 1988, is thought to be used by athletes in aerobic sports for the purpose of increasing oxygen transport and aerobic power. In an attempt to identify EPO administration, we have studied the peripheral blood of 20 subjects practising sports at an amateur level. Automated cytometry was performed on the blood samples before and during 45 days of EPO treatment. The same hematological indices were determined for a control population that consisted of 240 elite athletes from various sports. As expected following EPO treatment, RBC, [Hb] and Hct increased significantly (increments of 8%, 6.3% and 11%, respectively). A significant increase in reticulocyte count was also observed. In addition, automated erythrocyte analysis showed a significant increase in cells with a volume > 120 fl and hemoglobin content (HC)